We are a clinical-stage biopharmaceutical company developing novel precision peptide therapies to treat endocrine and metabolic diseases. (Incorporated in Delaware) Our leading drug candidate, MBX 2109, is a parathyroid hormone peptide designed as a potential long-acting hormone replacement therapy for chronic hypoparathyroidism.  Our company was founded by global leaders with a transformative approach to peptide […]

Note: Job Aire Group withdrew its IPO plans in a letter to the SEC dated April 12, 2025. We are a 16-year-old professional services company with demonstrated expertise and excellence in providing comprehensive staffing solutions across various facets of the aviation industry. (Incorporated in  Arizona)  Over the years, we have built a strong reputation for […]

Our mission is to provide customers with innovative solar installation services, promote eco-friendly resources, and achieve carbon neutrality. (Incorporated in the British Virgin Islands) We are a pure-play end-to-end EPCC solutions provider for solar PV facilities in Malaysia. Our primary focus is on two key segments: large-scale solar projects and commercial and industrial (C&I) solar projects. (Note: In […]

We are a newly organized blank check company. (Incorporated in the Cayman Islands)  We intend to seek to acquire small cap businesses exhibiting substantial potential in emerging markets driven by innovative technologies or novel business models. We believe these industries are attractive for a number of reasons, including: they represent attractive markets, which are characterized […]

We are a newly incorporated blank check company. (Incorporated in the Cayman Islands) We may search in any sector and in any geographic region for a target company for an acquisition or an initial business combination. James J. McEntee, III has served as our Chief Executive Officer and Chairman since inception. He is the Chairman of the Board […]

We are a clinical-stage biopharmaceutical company targeting head and neck squamous cell cancer with our leading drug candidate, ficerafusp alfa, a bifunctional antibody to target solid tumors. (Incorporated in Delaware) We are evaluating ficerafusp alfa in an ongoing Phase 1/1b clinical trial in the U.S. to treat patients with head and neck squamous cell cancer. […]

We are a clinical biotech company developing new therapies for MS (multiple sclerosis) and other autoimmune disorders. (Incorporated in Delaware) We are a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need.  Our lead I&I (immunology and inflammation) product candidate, obexelimab, is […]

(Note: Fuxing China Group Ltd. withdrew its plans for its small IPO on Nov. 20, 2025, in a letter to the U.S. Securities and Exchange Commission.) Through our operating subsidiaries in mainland China and Hong Kong, we are principally engaged in the production and sale of zipper sliders and zipper chains, trading of textile raw […]

We are a newly incorporated blank check company that will focus on TMT businesses. (Incorporated in the Cayman Islands) We intend to focus our efforts on businesses in the technology, media and telecommunications (“TMT”) sector as well as sectors that are being transformed via technology adoption, where we believe our management team’s operational and investment […]

Our operating company, HomesToLife Singapore, is one of the leading home furniture retailers that offers and sells customized furniture solutions in Singapore. As of the date of this prospectus, HomesToLife Singapore has six retail store locations – making it the second largest in Singapore by the number of retail store locations. (Incorporated in the Cayman […]